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Background: “Optical biopsy” using bronchoscopic probe-based confocal endomicrosocopy
(pCLE) provides real time images of the autofluorescent elastin scaffold of the healthy
acinus.
Objectives: To establish how different parenchymal lung diseases (PLDs) alter the pCLE
image, if intravenous fluorescein provides additional diagnostic information, and to assess
pCLE’s safety for investigating PLDs (UK REC: 09/H0708/18).
Methods: 116 bronchopulmonary segments were examined in 38 patients and 4 healthy
non-smoker volunteers. pCLE images were correlated with consensus multidisciplinary
diagnosis from HRCT, bronchoalveolar lavage, and transbronchial/CT guided biopsies.
Results: Severe emphysema is evident on pCLE imaging, with increased spacing between
septal walls, sudden loss of fluorescence from bullae and a subsequent reticular pleural
image. Other PLDs demonstrated marked loss of lobular autofluorescence and distinctive-
ness. In all diseases imaged, differentiation between septal wall and microvessel elastin is
more difficult in diseased versus healthy acini. Smokers displayed a hyperfluorescent 15-30
micron cellular alveolar infiltrate - alveolar macrophages on in vitro BAL analysis. Varied
intravenous fluorescein doses only create a hyperfluorescent foreground with bubbles. pCLE
can cause pleuritic discomfort but there were no pneumothoraces. 3 patients had transient
bleeding, and in vivo tearing of septal walls and microvessels abutting the probe was
observed.
Conclusions: Marked emphysema is demonstrable from loss of elastic walls. The detail of
high-resolution pCLE images is attenuated in other PLDs without further clarity from intrave-
nous fluorescein. Nevertheless, pCLE is safe for PLD investigation. These findings form a basistitute for Robotic Surgery, Bessemer Building, Imperial College London, South Kensington Campus,
l.: þ44 7980005675; fax: þ44 02075945196.
@yahoo.co.uk (R.C. Newton), pallav.shah@imperial.ac.uk (P.L. Shah).
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128 R.C. Newton et al.for future work to harness pCLE’s potential utility as part of a multiassessment modality for
PLD diagnosis.
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To accurately diagnose many parenchumal lung diseases
(PLDs) or solitary peripheral nodules, a multidisciplinary
assessment is required.1 This combines information from the
clinical presentation, interpretation of the high-resolution
computed tomography (HRCT) images, and microbiological,
cytological, and histopathological clues provided by bron-
choscopy. Histopathological analysis has the greatest influ-
ence upon establishing a diagnosis,2 but it does not always
provide a definitive answer3 and is not free from risk. Indeed,
a blind transbronchial biopsy (TBB) carries a 1e12% risk of
pneumothorax,4e7 and a 2e9% risk of bleeding.5,8,9 For
lesions that are inaccessible toTBB, the risks of percutaneous
or video assisted thoracoscopic biopsies are greater.3,10
Autofluorescence imaging,11 narrow band imaging,12 and
optical coherence tomography13 are some of the encour-
aging biophotonic techniques that are being studied as
adjuncts to white-light bronchoscopic imaging and tissue
biopsy, but their size prohibits deployment beyond the
larger airways. Even the thinnest bronchoscope has
a diameter of 2.7 mm.14 However, recent miniaturisation of
the confocal microscope has provided a means of acquiring
3.5 mm resolution images of the upper airways15e17 and also
the acini18,19 in vivo. With probe-based confocal endomi-
croscopy (pCLE) of the peripheral lung, a stiff 1.4 mm
diameter probe is inserted through the biopsy channel of
a standard bronchoscope into the alveolar duct; it transmits
488 nm blue argon laser light via 30,000 optical fibres. The
probe then detects the fluorescent elastin scaffold of the
acinus, and a real time image of the arching elastic fibres
forming the backbone of alveoli and blood microvessels is
provided on screen. If adjacent images can be readily
tracked during steady probe translation, the field of view
(FOV) can, in theory, be increased using the device’s
“mosaicing” software.20 In current smokers, the image also
displays highly fluorescent mobile macrophages. An initial
in vivo study in 41 healthy subjects has found pCLE to be
safe, and has enabled the basic morphology of the resolved
structures to be described.19Aims and objectives
This hypothesis-generating prospective observational study
was designed to explore a potential role for pCLE in
investigating different PLDs. The first aim was to evaluate
its ability to detect morphological changes evident in
specific diseases. In the brief history of endoscopic pCLE,
the gastrointestinal mucosa has been the major organ
target.20 Here, unlike in the elastin rich lung, exogenous
fluorescent contrast agents such as intravenous fluorescein
or topical acriflavine are required to delineate the cellular
architecture of the glands embedded within the epithe-
lium, and demonstrate dynamic in vivo blood flow.21,22
Therefore, the second aim was to establish if intravenousfluorescein provided additional in vivo information in pCLE
imaging of peripheral lung in health and disease (such as
improved delineation of vasculature). The third and final
aim was to assess the safety of pCLE in PLD patients. The
results from the first 17 subjects have been previously re-
ported in the form of an abstract.23
Materials and methods
Subjects
We performed pCLE in 1) healthy non-smoker volunteers, 2)
patients with chronic obstructive pulmonary disease
(COPD), and 3) patients with other diverse PLDs during their
diagnostic bronchoscopy. The healthy subjects had no
significant cardiorespiratory disease or bleeding diathesis.
All COPD and other PLD patients had HRCT scans performed
prior to bronchoscopy. Emphysema severity on HRCT was
graded 1-4.24 All subjects gave prior written informed
consent. The study was approved by the Brompton, Hare-
field & NHLI Research Ethics Committee (09/H0708/18).
Bronchoscopy
Subjects had topical local anaesthesia applied and were
given conscious sedation if required (1e5 mg midazolam).
They were given 2 L/min oxygen via nasal prongs and moni-
tored with pulse oxymetry. The pCLE laser unit and probes
were standard and commercially available (Cellvizio-Lung,
Mauna Kea Technologies, France) producing a 600 mm
diameter FOV at 12 frames per second, at an imaging plane
depth of up to 50mm. Subjectswere reclined at 45. The laser
unit was warmed up for 15 min before recalibration, and the
auto-power setting used. An Olympus 1T260 bronchoscope
was used to evaluate the central airways and then advanced
into the most distally accessible bronchi, whereupon the
probe was gently advanced beyond the distal opening of the
working channel until recognisable images were obtained of
the acinus. During normal respiration, successive pCLE video
loopswere acquired of up to six bronchopulmonary segments
(BPSs) named according to international nomenclature.25 In
each PLD patient, an attempt was made to optically biopsy
contrasting BPSs, displaying both maximal and minimal
radiological signs of disease. Where clinically indicated,
bronchoalveolar lavage (BAL)was performed using 100mls of
0.9% saline, and TBB was performed with Olympus EndoJaw
disposable biopsy forceps (Model FB-211D). Diagnosis in two
patients required subsequent CT-guided percutaneous
biopsy. All patients undergoing transbronchial biopsies had
post-procedure erect chest radiographs performed.
For the first 5 patients who underwent BAL/TBB corre-
lation, an extended working channel (outer sheath) was
initially deployed through the working channel and blindly
wedged distally to improve the likelihood that pCLE, BAL
and TBB were all obtained from the same location.
Confocal endomicroscopy for parenchymal lung diseases 129During continuous pCLE video acquisition at the end of
five bronchoscopies, incremental doses of intravenous 1%
fluorescein (Martindales, UK) were injected through
a peripheral cannula. A saline flush and a 90 s interval of
continuous imaging separated all boluses. A total of 20 mls
was administered into the first subject (healthy volunteer)
in 5 mls boluses; a final dose which approaches that used in
gastroenterological pCLE. The subsequent 4 subjects (2
healthy volunteers and 2 with emphysema) had substan-
tially smaller incremental doses of 0.1 ml, 0.25 ml, 0.4 ml
and 1 ml.
BAL/TBB analysis and definitive diagnosis
Differential cell separation, cytopathological examination,
and microbiological culture were performed on all BAL fluid
samples. Where there was spare BAL fluid, constituent cells
were differentially separated, resuspended, and ex vivo
pCLE imaging performed. TBB samples were fixed in
formalin, embedded inwaxand5mmsectionswereexamined
by an expert pathologist. In accordance with current guide-
lines,1 all available data was discussed at a multidisciplinary
team meeting to reach a diagnostic consensus.
pCLE image acquisition, processing and
interpretation
pCLE video loops were recorded in each BPS until a consis-
tent image had been obtained. At least five representative
stills were created for each video, for subsequent qualita-
tive appraisal by two observers (RN & PS) using Cellvizio
Viewer software (Mauna Kea technologies, France),Figure 1 Still pCLE images in A,B & C are from healthy BPSs and
thickness). Age seems to play a role in the septal wall fluorescence
29). Mosaicing was able to increase the FOV in 65/116 BPSs: D sho
a 150 mm microvessel with a small branch (from a BPS with gradeincluding an assessment of the septal walls and vessels
(autofluorescence intensity, regularity of structure) and
any fluorescent cellular infiltrate. The Cellvizio Viewer
software’s mosaicing function was used to create auto-
mated mosaics. For each video sequence that enabled
mosaic construction, the longest individual mosaic axis was
recorded as a quantification of how well the FOV could be
retrospectively increased. SPSS was used for statistical
analysis.Results
Subjects
Bronchoscopic pCLE videos and still images were obtained
from 4 control volunteers and 1 lung-disease free patient
(normal HRCT but cutaneous erythema nodosum) (mean
age 34.8  9.7) (Fig. 1AeC), together with 38 patients
(mean age 54.9  11.8). BAL, TBB and CT guided biopsy
were performed in 23, 21 and 2 patients respectively. Of
the TBBs, 2/21 (9.5%) yielded no alveolar parenchyma, 4/21
(19%) provided pathognomic features, another 7/21 (33.3%)
provided essential information for the diagnosis, and the
remaining 8/21 (38%) were non-specific. Final diagnoses
were COPD (13 patients mean age 61.7  6.8), or other PLD
(24 patients mean age 48.9  13.6) (Table 1). The only two
current smokers were PLD patients (sarcoid and respiratory
bronchiolitis). The single chronic bronchitis patient had
smoked until 2 weeks before bronchoscopy. RB1 and LB1/2
were the only BPSs that were not always possible to can-
nulate, but this occurred only during 4 bronchoscopies.
Previously, cannulation of these BPSs has been regarded asshow fine undistorted septal wall elastin architecture (<10 mm
intensity (A and B are from a 52 year old patient; C was aged
ws the longest mosaic created (1268 mm); the oval highlights
1 emphysema).
Table 1 The main diagnoses of the 42 subjects broncho-
scoped, providing the 116 BPSs that were imaged.
Number of
subjects
(main
diagnosis)
Overall
number of
affected BPSs
imaged
Healthy
Volunteers 4 19
Nil abnormal on CT, TBB &
BAL, or remote from
diseased area
1 8
Subtotal 5 27
COPD
Grade 1 emphysema 2 2
Grade 1 emphysema with
partial collapse
1 1
Grade 2 emphysema 0 3
Grade 2 emphysema with
mild infection
0 1
Grade 3 emphysema 0 3
Grade 3 emphysema with
mild infection
1 1
Grade 4 emphysema 8 15
Chronic bronchitis 1 3
Subtotal 13 29
Other parenchymal lung
diseases
Respiratory bronchiolitis 1 5
Pulmonary sarcoidosis 4 12
Mild radiotherapy damage 1 1
Tuberculosis 1 4
Pulmonary fibrosis with
infection
1 1
Drug-induced pneumonitis 2 3
Peri-chemotherapy pneumonia 7 19
Amyloidosis 1 2
Peripheral non small cell
lung cancer
1 1
Bronchioloalveolar carcinoma 1 5
Metastatic cancer (breast,
endometrial or fibrosarcoma)
4 7
Subtotal 24 60
Total 42 116
130 R.C. Newton et al.impossible owing to probe stiffness.19 Each subject had 1-6
BPSs optically biopsied creating 116 pCLE videos for anal-
ysis. The extended working channel was used for the first 5
subjects, but following concern that it was slightly
impeding the action of the TBB forceps and the fluid flow
for the BAL, it was abandoned.pCLE images of emphysema
It is evident from studying the 116 video loops and repre-
sentative stills, that the appearance of copious, regular,
10 mm elastic fibres within the alveolar septal wall structure
previously described in healthy subjects,19 and illustrated
in Fig. 2, becomes variably disorganised in all peripheraldiseases (Table 2). For example, pCLE highlights some of
the morphological alterations in severe emphysema, the
main one being a loss of the number of septal walls (Fig. 2).
In many cases there is distortion of the remaining emphy-
sematous septal walls, or thickening that leads to an
inability to distinguish septal wall from microvessel (Figs.
2c and 4). In 2 emphysematous BPSs containing large
bullae, a sudden black image was followed by a fine retic-
ular pattern, suggesting the possibility that the inner
surface of the visceral pleura had been reached via a bulla
(Fig. 2E and F).pCLE images of other PLDs
In most parenchymal lung diseases other than emphysema,
the pCLE architecture becomes unrecognisable (Figs. 3 and
4f). The autofluorescence is substantially reduced and the
images become indistinct and noisy. The most radiologically
affected areas tend to display the most disruption and loss
of autofluoresence in their corresponding pCLE images. This
contrasts with BPSs exclusively affected by emphysema
which, as described, have a smaller number of septal walls
per FOV, creating the appearance of “holes”, but they do
not appear to lose autofluorescence intensity, and the
elastin scaffold of the acinus tends to retain its distinc-
tiveness even in severe disease, even if sometimes vessels
become indistinguishable from septal wall.
Whilst the septal wall structure was more distinct in
healthy volunteers than in subjects with marked disease,
the autofluorescence was generally weaker than healthy or
emphysematous areas of older patients. This effect of age
on autofluorescence has previously been described.19Inflammatory cells
The appearance of undetermined 3 mm specks (particularly
on approach to the acinus), mucus globules/bubbles or
even faint inflammatory cells is a non-specific finding to
healthy and diseased areas (Fig. 5). However, brightly
autofluorescing 15e30 mm cellular infiltrates were exclu-
sively observed in the BPSs of the only 2 current smokers in
the study (respiratory bronchiolitis and sarcoid), as well as
one recently ex-smoker with chronic bronchitis. The 3 other
sarcoidosis patients were non smokers and their in vivo
pCLE and ex vivo BAL pCLE images had no visible inflam-
matory cell infiltrate. Differential cell separation of the 2
current smokers’ BAL fluid demonstrated that the respon-
sible cells were autofluorescent macrophages. The subject
with chronic bronchitis had endobronchial washings only,
which displayed no ex vivo fluorescent cells.Mosaic function
The automated mosaic function was used on the Cellvizio
Viewersoftware. Mosaics were creatable for 65/116 video
loops, but the mean maximum mosaic length was a modest
757  125 mm. Video loops with bright distinct images,
where there was some controlled movement of the probe
tip tended to yield longer mosaics (Fig. 1D).
Figure 2 The number of visible septal walls tends to reduce as emphysema worsens: grade 1 emphysema (A), grade 4 (B). C and D
are images near large bullae. The ellipse in C highlights arching fibres that probably represent distorted and thickened septal wall,
though using discrimination by thickness they could alternatively be microvessel. D shows a probable vessel but minimal septal
wall. E and F are images of pleura beyond bullae.
Confocal endomicroscopy for parenchymal lung diseases 131Intravenous fluorescein
With intravenous fluorescein 1%, 0.25 mls was the minimum
required to observe a change. This change consists of
a hyperfluorescent foreground containing non-fluorescent
bubbles; it appears within a few seconds of drug adminis-
tration and is not initially confined to the microvessels (as
might be expected) (Fig. 6). Therefore, there is no
discernible increase in the autofluoresence of the septal
walls, microvessels or cells during incremental administra-
tion of the drug.Table 2 A summary of the observations and measurements from
with emphysema is most likely to appear distorted, structures ten
autofluorescence and recognisable distinct structure is common i
chi-square tests for the other observations).
Observation Health
(N Z 2
Decreased autofluorescence of individual elastic
structures (p Z 0.002)
12/27
Unrecognisable structure & decreased
distinctiveness (p Z 0.000000056)
7/27 Z
Distorted septal wall morphology
(p Z 0.000000097)
1/27 Z
Snapped septal walls or vessels (p Z 0.00019) 2/27 Z
Autofluorescent macrophages (15e30 mm &
mobile) (p Z 0.075)
0/27 Z
Mucus globules/bubbles (p Z 0.935) 9/27 Z
3 mm specks (p Z 0.108) 6/27 Z
Are mosaics creatable? (p Z 0.0000091) 7/27 Z
Mean maximum mosaic length (mm)
(p Z 0.00042)
691 
a The few BPSs displaying autofluorescent macrophages were from
b A COPD patient who had only quit smoking 2 weeks previously.Safety and acceptability
To acquire adequate pCLE footage for subsequent analysis,
each BPS imaged added a mean of 112  48.9 s to the
bronchoscopy procedure (prior to any fluorescein based
imaging). During or after pCLE, prior to TBB, blood origi-
nating distal to the bronchoscope tip, along the path of the
probe towards the acinus, impaired the bronchoscopic view
in 3 patients by seeping proximally into the subsegmental
bronchus. However, all bleeding was minimal and sponta-
neously resolved without further complication or need forthe 116 BPSs analysed. Whilst the elastin scaffold morphology
d to be vivid and brightly autofluorescent. Diminution of both
n other PLDs (ANOVA was used for mosaic length, and 2-sided
y/Normal
7)
COPD
(N Z 29)
Other PLD
(N Z 60)
Z 44.4% 1/29 Z 3.4% 19/60 Z 31.7%
25.9% 5/29 Z 17.2% 45/60 Z 75%
3.7% 22/29 Z 75.9% 35/60 Z 58.3%
7.4% 15/29 Z 51.7% 11/60 Z 18.3%
0% 3/29 Z 10.3%b 10/60 Z 16.7%a
33.3% 11/29 Z 37.9% 21/60 Z 35%
22.2% 8/29 Z 27.6% 26/60 Z 43.3%
25.9% 26/29 Z 89.7% 32/60 Z 53.3%
84.9 829  148 714  78.4
the only two current smokers in the study, both with other PLDs.
Figure 3 Many PLDs cause a non-specific loss of fluorescence and distinctiveness. This is demonstrated with a peripheral
metastatic fibrosarcoma deposit (A), an organising pneumonia (B), and an area of lung affected by a lymphocytic infiltration
secondary to a peri-chemotherapy pneumonia (F). In a patient with bronchioloalveolar carcinoma, HRCT showed severely affected
upper lobes (D), and pCLE provided virtually no recognisable autofluorescence within the right upper lobe (C) whereas the spared
right lower lobe showed distinct alveolar structures with greater autofluorescence (G). E was acquired from maximal distal can-
nulation of LB6 in a patient with tracheobronchial amyloidosis: the “cotton wool like” autofluorescence was similar to that
observed in pCLE of endobronchial amyloid deposits.26
132 R.C. Newton et al.intervention. Of note, one of these patients had a clotting
abnormality (prothrombin time of 19 s), and within the
probed BPS of another patient was a metastatic breast
tumour displaying microvessel invasion. Nevertheless,Figure 4 In health, differentiation between microvessels and se
tics.19 This is not as straightforward in diseased BPSs, and here the c
cannot be identified as either structure on the basis of their shap
(grades 2, 3, 3, 4, and 4 respectively) and F is from a BPS with druthere was clear observation of a microvessel being snapped
in vivo by the probe in three separate BPSs (Fig. 7E, see
online supplement for videos). The probe sometimes cau-
ses pleuritic pain during image acquisition, but there wereptal walls (Fig. 1) is done on diameter and shape characteris-
ircles show indeterminate structures from diseased BPSs which
e or intermediate calibre. A-E are from emphysematous BPSs
g-induced pneumonitis.
Figure 5 Bright indeterminate 3 mm specks are common on approach to the acinus regardless of smoking status (A is from
a patient with pneumonia). Apparent mucus blobs or bubbles are non-specific (B is from a resolving pneumonia, and C is from a BPS
with grade 3 emphysema). Whilst some very faint cells are suggested even in non-smokers, brightly autofluorescing alveolar
macrophages are exclusive to smokers (or those with a recent smoking history) regardless of disease (D&E are from RB4 and RB6 of
a recently quit heavy ex-smoker with chronic bronchitis). F shows that these macrophages sometimes “drown out” the alveolar
walls (respiratory bronchiolitis).
Confocal endomicroscopy for parenchymal lung diseases 133no pneumothoraces. The largest fluorescein dose injected
caused retching during the procedure in one healthy
subject. Seemingly snapped elastic fibres of the septal
walls flapped around on the video loops of 28 BPSs
(Fig. 7AeD). It is possible that pre-existing disease may
create or predispose to this disruption; it was indeed more
commonly observed in COPD BPSs than in areas that were
affected by other PLDs or healthy lung. Nevertheless, direct
damage from the probe was witnessed in 6 BPSs as septal
walls snapped during image acquisition (Fig. 7D).
Supplementary video related to this article can be found
at doi:10.1016/j.rmed.2011.09.009.Discussion
A previous study has demonstrated that pCLE accurately
displays the morphology of the elastin microskeleton within
the healthy acinus,19 which has led to speculation that
pCLE may provide diagnostic clues in peripheral lung
diseases.18,27,28 This study has described the feasibility and
findings of pCLE imaging in a group of patients with varied
parenchymal diseases.
Regarding image interpretation, the best case scenario
was that alterations to elastin would be specific to individual
diseases and provide unique image features such that, for
example, non-necrotising granulomas were visible in
sarcoidosis,29 and the fibrotic zones of dense collagen found
in pulmonary fibrosis were enough to specifically alter the
elastin appearance.30 However, the pathognomonic featuresof specific diseases, observed under standard haemotoxylin
and eosin histopathologicalmicroscopy are unlikely tomatch
the changes occurring to the elastin. Nevertheless, elastin
structure and production is known to alter in lung dis-
ease,31e34 and themost salient image finding from this series
is the degree towhichmany peripheral diseases (emphysema
excluded) are able to create a non-specific attenuation of
the stunning highly recognisable images of healthy acini. The
observed loss of distinctiveness and autofluorescence in the
non-emphysematous diseaseswithin this studymaybedue to
elastin destruction, alveolar collapse or substances such as
collagen, blood, inflammatory infiltrate or mucus impeding
the incident laser light and emitted autofluorescence.
Predictably,19 the autofluorescence intensity of indi-
vidual fibres was greater in the older subjects; the healthy
volunteers were young and whilst their individual septal
walls were generally distinct, they displayed consistently
weaker autofluorescence than from older non-diseased
BPSs, or those BPSs only affected by emphysema.
It appears that severe emphysema is often evident on
pCLE imaging with dark holes and a reduction in the number
of septal walls visible in each frame. Residual elastin is
often thickened or disrupted. This is perhaps logical,
considering that a major feature of COPD is fragmentation
and loss of alveolar elastin.35 It remains to be established
whether these are sufficiently reliable diagnostic findings,
and whether milder disease is adequately demonstrable. If
so, pCLE could be employed to grade the severity of
emphysema for trials, or to assess the efficacy of inter-
ventions. Currently, subclinical COPD in asymptomatic
smokers is screened for using spirometry36 but whilst much
Figure 6 Compared to standard biopsy, there is reduced resolution/diagnostic information with conventional elastin auto-
fluorescence pCLE: from the same sarcoid BPS, compare the H&E stained TBB (autofluorescent microscopy 200) (A) of a patho-
gnomonic non-necrotising granuloma to the non-specific disruption seen with pCLE (B). The administration of intravenous
fluorescein does not provide additional information: it causes a general white appearance of the mucus/surfactant (C shows
a healthy BPS following injection of 5 ml of 1%) with bubbles displacing the contrast agent. All other acinar structures are disguised.
Even when tiny quantities are used (such as 0.4 ml of 1% in D), the microvessels (marked by the ellipse) are no more distinct, but
bubbles are still evident where the newly fluorescing mucus is being disturbed.
134 R.C. Newton et al.more invasive, pCLE could have an additional diagnostic
role, particularly if it had greater sensitivity for detecting
early morphological damage which was predictive for
future symptomatology. However, centrilobular emphy-
sema tends to be heterogeneous which will inevitably
create sampling bias; a particular problem in alveolar pCLE
where to image a new area, mural restraint of the probe
necessitates blind reinsertion into the BPS in the hope of
cannulating a different terminal bronchiole. Conversely,
the homogeneity of panacinar emphysema in alpha-1-
antitrypsin deficiency makes early diagnosis difficult using
HRCT; this provides a possible niche for pCLE. In this study,
it should also be highlighted that two patients with bullae
inadvertently had what is likely to be the first described
in vivo bronchoscopic imaging of the inner surface of the
elastin rich visceral pleura.37
Thiberville et al. bronchoscoped 41 healthy volunteers
and confidently measured the septal walls as being
10 2.7 mm and the microvessels as 90 50 mm.19 However,
in the diseased BPSs, discrimination between these two
image components was often impossible. This is likely due to
pathological disruption of the elastin architecture forming
the septal walls and microvessels,38e40 along with in many
BPSs, the disease related reduction of image distinctiveness
and autofluorescence described.
Using the mosaicing software, the standard 600 mm FOV
could only be modestly increased in just over half of the
BPSs overall, and only two BPSs yielded mosaics >1 mm.
Unlike pCLE in less constrained areas, such as the proximalendobronchium or the gastrointestinal lumen, the probe
cannot easily be translated, and within the acinus gentle
withdrawal or further advancement does not always
provide adjacent images to stitch together. The mosaicing
function was likely impaired by fainter septal walls in the
younger subjects, and distinct feature loss in non-
emphysematous disease.
Whilst this series included only three current or recently
quit smokers, the previous finding in healthy subjects that
bright autofluorescent macrophages are specific to smokers
or ex-smokers,19 seems to remain true in disease. Whilst
there was a suggestion of similarly sized faint cells in the
acinae of several subjects, the inflammatory cells in the
video loops from the current and recently quit smokers
were very bright and clearly independently mobile and
therefore distinct from the septal walls they were within.
The smokers’ BAL fluid uniquely demonstrated fluorescent
cells (macrophages). The fluorescence imparted upon
alveolar macrophages from cigarette smoking takes years
to fully diminish41 and there is in vitro evidence that air
pollutants have a similar effect on macrophage fluores-
cence.42 These factors could explain any less obvious fluo-
rescent cellular infiltrates. Further work is needed to
elucidate the identity of the mucus globules/bubbles and
the bright 3 mm specks.
The prediction of probe destination remains an issue.
Even in Thiberville et al’s healthy cohort, over 10% of
cannulated BPSs failed to provide an alveolar image,19
presumably because of an inability to adequately deploy
Figure 7 Free ends of septal walls, observed on video loops to flutter loosely, were apparent in 28/116 BPSs (highlighted with
circles in A, B, C and D). This phenomenon could be partly illustrative of the primary disease, however, in 6 BPSs, individual septal
walls were observed to fracture, separate and then their blind ends swing freely, presumably from the axial pressure of the probe
(demonstrated in C, and in D across 3 sequential frames; each separated by 83 ms). Microvessels were also observed to snap under
axial pressure in 4 BPSs (highlighted by an oval in C, and sequential frames shown in E). A is from a grade 1 emphysema BPS, B, C
and E are from different grade 3 and 4 BPSs, and D is from a patient with respiratory bronchiolitis (see online supplement for
videos).
Confocal endomicroscopy for parenchymal lung diseases 135or position the probe beyond the respiratory bronchiole. In
severely diseased BPSs it was difficult to ascertain if
a reduction in image quality represented this incomplete
deployment, or if the probe was imaging a bulla/diseased
area. Similarly, it is not possible to confirm that the pCLE
image was taken from exactly the same location as the
diagnostic TBB and BAL. Whilst the TBB forceps and pCLE
probe both follow the path of least resistance, and are of
similar diameter and stiffness, they were blindly deployed
into the subsegmental bronchus. Whilst the possibility of
multiple potential terminal destinations of the pCLE probe
and TBB forceps is of minimal consequence in BPSs affected
by diffuse homogeneous disease, focal or patchy disease
may cause difficulty with reliable correlation, justifying
fluoroscopic guidance. In this study, an extended working
channel was trialled but abandoned owing to ergonomic
concerns during BAL and TBB.
Intravenous fluorescein is themodus operandi for pCLE in
theGI tract by highlighting the calibre, course and leakage of
microvessels,43 as well as providing fluorescence of the
epithelium and glands. For this study, it was postulated that
intravenous fluorescein might facilitate the discrimination
between microvessels and septal walls, and therefore might
have a role in diagnosis. However, there was noconcentration that provided a useful role in peripheral lung
pCLE imaging as there is “white-out” of the image before
delineation of any microvessels can take place. Unbound
fluorescein is a small hydrophilic molecule, used as
a permeability marker,44 and thus is likely to be diffusing too
rapidly through the highly permeable endothelial monolayer
into the surfactant to preferentially outline microvessels. A
recent small study using only afixed doseof IV fluorescein has
suggested that there may be subtle differences in the dark
bubbles in health and disease, though this was not our
finding.18 Nausea and wretching were induced by the fluo-
rescein in one patient, but this is well recognised in gastro-
intestinal pCLE.45 Additional information for acinar pCLE
imaging may be gleaned in the future by using topical
contrast agents such as cresyl violet and methylene blue
which penetrate the cell membrane; these have been briefly
described in the upper airways17 and peripherally.27
This study has demonstrated that pCLE is quick and safe
for patients with PLDs. Minor self-limiting bleeding in 3
patients was no more significant than that sometimes
observed in other bronchoscopic procedures; even for
a patient with a slight coagulation abnormality. Whilst the
probe can cause pleuritic pain, no pneumothoraces were
identified during the study. However, damage to the
136 R.C. Newton et al.delicate pulmonary acinus cannot be excluded. For
example, the terminal and respiratory bronchioles are
substantially narrower than the 1.4 mm diameter probe.46
Whilst grossly magnified, free ended swaying septal walls
were observed in 28 BPSs. Sometimes, this may be the
product of lung disease, (more were observed in the
emphysematous BPSs) but the probe was shown to be the
likely culprit in several videos where the traumatic tearing
of vessels and delicate septal walls was observed in real
time. Whether this has any minor clinical significance
remains to be established, but the areas affected are tiny,
and the trauma should still be less than for TBB.Conclusion
An in vivo instrument such as pCLE has theoretical advan-
tages over conventional histology. Within the acinus, we
observed bothmobile cells and cyclical movement related to
respiration. There were no significant complications and
there was no delay or alteration (from histological prepara-
tion) to the structure observed. However,with the exception
of emphysema, there is significant diagnostic information
lost with pCLE as compared with histopathology. Whilst this
study provides a basis to develop pCLE for PLD imaging,
furtherwork is neededbefore it can beused to either provide
accurate diagnosis without tissue biopsy, or simply indicate
the optimal subsegmental bronchus for the forceps to
enhance the yield of TBB. In addition to the use of intracel-
lular contrast agents as previously mentioned, pCLE imaging
of endogenous structures other than elastin may also be
realised by employing combinations of confocal wavelengths
to provoke simultaneous autofluorescence from multiple
endogenous sources such as collagen,47 or by combining
“fluorescence lifetime imaging” with confocal endomicro-
scopy to add molecular contrast to images by displaying the
fluorescence decay profiles.48Acknowledgements
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